[Ulcerative colitis. Maintenance therapy].
Kruis
W
W
Abt. Innere Medizin, Evangelisches Krankenhaus Köln-Kalk.
Schreiber
S
S
D000284:Administration, Oral; D000285:Administration, Rectal; D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000517:prevention & control; D018849:Controlled Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D018579:Patient Selection; D010919:Placebos; D011349:Proctitis / Q000188:drug therapy; D012074:Remission Induction; D013488:Suppositories; D013997:Time Factors
D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D010919:Placebos; D013488:Suppositories; D015122:Mercaptopurine; D001379:Azathioprine; D001241:Aspirin
Remissionserhaltung.